AG
WVE icon

Artal Group’s Wave Life Sciences WVE Stock Holding History

Artal Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,566,251
Closed -$22.8M – 98
2024
Q2 		$22.8M Buy
4,566,251
+514,851
+13% +$2.94M 0.58% 22
2024
Q1 		$25M Buy
4,051,400
+1,044,000
+35% +$5.23M 0.64% 22
2023
Q4 		$15.2M Buy
3,007,400
+1,007,400
+50% +$5.38M 0.5% 27
2023
Q3 		$11.5M Sell
2,000,000
-870,523
-30% -$3.97M 0.49% 33
2023
Q2 		$10.4M Sell
2,870,523
-129,477
-4% -$523K 0.32% 46
2023
Q1 		$13M Hold
3,000,000
– – 0.77% 32
2022
Q4 		$21M Hold
3,000,000
– – 1.17% 30
2022
Q3 		$10.8M Hold
3,000,000
– – 0.46% 41
2022
Q2 		$9.75M Buy
3,000,000
+2,000,000
+200% +$3.85M 0.52% 38
2022
Q1 		$2M Hold
1,000,000
– – 0.08% 113
2021
Q4 		$3.14M Hold
1,000,000
– – 0.09% 121
2021
Q3 		$4.9M Buy
+1,000,000
New +$6.06M 0.11% 115
2019
Q2 		– Sell
-250,000
Closed -$9.71M – 118
2019
Q1 		$9.71M Buy
+250,000
New +$10.1M 0.4% 53
2018
Q3 		– Sell
-100,000
Closed -$3.83M – 117
2018
Q2 		$3.83M Sell
100,000
-50,000
-33% -$2.15M 0.08% 77
2018
Q1 		$6.01M Buy
150,000
+57,922
+63% +$2.43M 0.08% 63
2017
Q4 		$3.23M Buy
+92,078
New +$2.68M 0.05% 81

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Artal Group's WVE Position: Q3 2024 in Review

Artal Group sold out of Wave Life Sciences (WVE) in Q3 2024, closing a stake of 4,566,251 shares — an estimated $22.8M sold.

Artal Group first reported a position in WVE in Q4 2017 and held it in 16 quarters. The position peaked at $25M in Q1 2024. 162 funds tracked by Wall St. Rank hold WVE as of Q3 2024.

  • Artal Group reported no remaining Wave Life Sciences position as of Q3 2024 after selling out during the quarter.
  • Artal Group sold 4,566,251 Wave Life Sciences shares in Q3 2024, an estimated $22.8M.
  • Artal Group first reported a position in Wave Life Sciences in Q4 2017 and held it in 16 quarters.
  • Artal Group's Wave Life Sciences position peaked at $25M in Q1 2024.
  • 162 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2024.

Based on Artal Group's 13F filing for Q3 2024, filed 13 Nov 2024.